The estimated Net Worth of Michael Robert Moynihan is at least $922 Тысяча dollars as of 29 September 2017. Michael Moynihan owns over 50,000 units of 22nd Century Inc stock worth over $246,290 and over the last 11 years Michael sold XXII stock worth over $675,500.
Michael has made over 6 trades of the 22nd Century Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Michael sold 50,000 units of XXII stock worth $133,500 on 29 September 2017.
The largest trade Michael's ever made was selling 100,000 units of 22nd Century Inc stock on 31 October 2016 worth over $128,000. On average, Michael trades about 35,000 units every 126 days since 2014. As of 29 September 2017 Michael still owns at least 867,220 units of 22nd Century Inc stock.
You can see the complete history of Michael Moynihan stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is 9530 MAIN STREET, , CLARENCE, NY, 14031.
Over the last 11 years, insiders at 22nd Century Inc have traded over $3,035,006 worth of 22nd Century Inc stock and bought 652,225 units worth $737,196 . The most active insiders traders include Andrew Arno, Joseph Pandolfino и Michael Zercher. On average, 22nd Century Inc executives and independent directors trade stock every 80 days with the average trade being worth of $16,372. The most recent stock trade was executed by Lawrence Firestone on 30 May 2024, trading 9,000 units of XXII stock currently worth $9,810.
with the mission of reducing the harm caused by smoking, 22nd century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. goodrich tobacco company and hercules pharmaceuticals are wholly-owned subsidiaries focusing on (i) premium cigarettes and potentially reduced risk tobacco products (with up to 97% less nicotine than conventional cigarettes), and (ii) the x-22 prescription smoking cessation aid in development. 22nd century's technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.
22nd Century Inc executives and other stock owners filed with the SEC include: